Psychedelics Investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
Psychedelics Investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
Psychedelics Investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
Psychedelics Investing Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023
Psychedelics Investing Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130
Psychedelics Investing Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
Psychedelics Investing Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC
Psychedelics Investing Lobe Sciences, Ltd. Announces USD$250,000 Convertible Note Financing and Warrant Issuance
Brunswick Exploration Announces Brokered Private Placement for Gross Proceeds of up to C$2.5 Million, with a Lead Order from a Strategic Investor
RETRANSMISSION: Group Eleven to be Featured on Radius Research for a Live Company Pitch, Deep Dive and Q&A Webinar
